✦ LIBER ✦

480 PRULIFLOXACIN VS PHOSPHOMYCIN: PROPHYLAXIS IN PATIENTS WITH RECURRENT UTI. PRELIMINARY RESULTS OF A RANDOMIZED MULTI-CENTRE STUDY

✍ Scribed by E. Costantini; E. Salvini; M. Lazzeri; E. Frumenzio; A. Cicalese; V. Li Marzi; M.T. Filocamo; M. Del Zingaro; A. Zucchi; L. Mearini; M. Porena

Book ID: 119622822
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 197 KB
Volume: 10
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(11)60471-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P1040 TENOFOVIR FOR THE PROPHYLAXIS OF H

P1040 TENOFOVIR FOR THE PROPHYLAXIS OF HBV REACTIVATION IN ANTI-HBC-POSITIVE PATIENTS WITH HEMATOLOGIC MALIGNANCIES TREATED WITH RITUXIMAB: PRELIMINARY RESULTS OF A RANDOMIZED STUDY (PREBLIN STUDY)

✍ Buti, M.; Morillas, R.; Manzano, M.L.; García-Retortillo, M.; Gutiérrez, M.L.; M 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 76 KB

4033 POSTER Preliminary results of late

4033 POSTER Preliminary results of late rectal and urinary toxicity in a phase II randomized study of conventional fractionation vs. hypofractionation on patients with high risk prostate cancer

✍ S. Gomellini; M.G. Petrongari; B.M. Saracino; S. Arcangeli; S. Marzi; V. Landoni 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 64 KB

4012 POSTER Preliminary results of the 2

4012 POSTER Preliminary results of the 2-year prostate re-biopsy in a phase II randomized study of conventional fractionation vs. hypofractionation on patients with high risk prostate cancer

✍ G. Arcangeli; S. Gomellini; B.M. Saracino; M.G. Petrongari; S. Arcangeli; S. Sen 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 62 KB

971 Preliminary results of a randomized

971 Preliminary results of a randomized study of 1 VS 2 910 MG/M/SQM doses of amifostine in high-RDI cyclophosphamide (CPM)-epirubicin (EDOX) in patients with high risk breast carcinoma

✍ C. Cuvier; A. Ardavanis; J.M. Extra; M. Espie; W. Oster; M. Marty 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 109 KB